Heat Biologics Stock Book Value Per Share
Heat Biologics fundamentals help investors to digest information that contributes to Heat Biologics' financial success or failures. It also enables traders to predict the movement of Heat Stock. The fundamental analysis module provides a way to measure Heat Biologics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Heat Biologics stock.
Heat |
Heat Biologics Company Book Value Per Share Analysis
Heat Biologics' Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Heat Biologics Book Value Per Share | 4.97 X |
Most of Heat Biologics' fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heat Biologics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
CompetitionIn accordance with the recently published financial statements, the book value per share of Heat Biologics is about 4.97 times. This is 392.35% lower than that of the Healthcare sector and 102.0% lower than that of the Biotechnology industry. The book value per share for all United States stocks is 99.74% higher than that of the company.
Heat Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heat Biologics' direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heat Biologics could also be used in its relative valuation, which is a method of valuing Heat Biologics by comparing valuation metrics of similar companies.Heat Biologics is currently under evaluation in book value per share category among related companies.
Heat Fundamentals
| Return On Equity | -31.12 | |||
| Return On Asset | -17.1 | |||
| Current Valuation | (34.74 M) | |||
| Shares Outstanding | 25.4 M | |||
| Shares Owned By Insiders | 5.20 % | |||
| Shares Owned By Institutions | 10.77 % | |||
| Number Of Shares Shorted | 1.17 M | |||
| Price To Earning | (1.29) X | |||
| Price To Book | 0.48 X | |||
| Price To Sales | 28.62 X | |||
| Revenue | 2.11 M | |||
| Gross Profit | (16.71 M) | |||
| EBITDA | (32.93 M) | |||
| Net Income | (35.07 M) | |||
| Cash And Equivalents | 96.38 M | |||
| Cash Per Share | 3.76 X | |||
| Total Debt | 1.93 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 21.04 X | |||
| Book Value Per Share | 4.97 X | |||
| Cash Flow From Operations | (38.13 M) | |||
| Short Ratio | 4.43 X | |||
| Earnings Per Share | (1.15) X | |||
| Number Of Employees | 49 | |||
| Beta | 0.3 | |||
| Market Capitalization | 60.46 M | |||
| Total Asset | 11.75 M | |||
| Retained Earnings | (107.35 M) | |||
| Working Capital | 6.77 M | |||
| Current Asset | 11.27 M | |||
| Current Liabilities | 4.5 M | |||
| Z Score | -0.6 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Heat Biologics information on this page should be used as a complementary analysis to other Heat Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Heat Stock
If you are still planning to invest in Heat Biologics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Heat Biologics' history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |